333 related articles for article (PubMed ID: 4042094)
1. Food and Drug Administration requirements for approval of new anticancer drugs.
Johnson JR; Temple R
Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
[TBL] [Abstract][Full Text] [Related]
2. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.
Beitz J; Gnecco C; Justice R
J Natl Cancer Inst Monogr; 1996; (20):7-9. PubMed ID: 8750460
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
4. Targeted agents: the rules of combination.
Kwak EL; Clark JW; Chabner B
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
[TBL] [Abstract][Full Text] [Related]
5. Cancer drugs. Weighing the risks and benefits.
Bren L
FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
[TBL] [Abstract][Full Text] [Related]
6. When are "positive" clinical trials in oncology truly positive?
Ocana A; Tannock IF
J Natl Cancer Inst; 2011 Jan; 103(1):16-20. PubMed ID: 21131576
[TBL] [Abstract][Full Text] [Related]
7. Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial.
Tsimberidou AM; Braiteh F; Stewart DJ; Kurzrock R
J Clin Oncol; 2009 Dec; 27(36):6243-50. PubMed ID: 19826112
[TBL] [Abstract][Full Text] [Related]
8. Accelerated approval of oncology products: a decade of experience.
Dagher R; Johnson J; Williams G; Keegan P; Pazdur R
J Natl Cancer Inst; 2004 Oct; 96(20):1500-9. PubMed ID: 15494600
[TBL] [Abstract][Full Text] [Related]
9. [A tentative of guideline for phase III study and its problems in clinical aspect].
Nakao I
Gan To Kagaku Ryoho; 1984 Mar; 11(3):395-403. PubMed ID: 6703719
[TBL] [Abstract][Full Text] [Related]
10. Assessing tumor-related signs and symptoms to support cancer drug approval.
Williams G; Pazdur R; Temple R
J Biopharm Stat; 2004 Feb; 14(1):5-21. PubMed ID: 15027497
[TBL] [Abstract][Full Text] [Related]
11. Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products.
Rock EP; Scott JA; Kennedy DL; Sridhara R; Pazdur R; Burke LB
J Natl Cancer Inst Monogr; 2007; (37):27-30. PubMed ID: 17951228
[TBL] [Abstract][Full Text] [Related]
12. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy.
Kane RC; Farrell AT; Sridhara R; Pazdur R
Clin Cancer Res; 2006 May; 12(10):2955-60. PubMed ID: 16707588
[TBL] [Abstract][Full Text] [Related]
13. Recasting cancer trials.
Nat Biotechnol; 2012 Jul; 30(7):567. PubMed ID: 22781659
[No Abstract] [Full Text] [Related]
14. Panel recommends changes to expedite approval of cancer, AIDS drugs.
Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248
[No Abstract] [Full Text] [Related]
15. [Current status and issues in clinical trials of anticancer agents].
Kojima H
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
[TBL] [Abstract][Full Text] [Related]
16. [Comparative clinical trials].
Yokoyama M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
18. EU law mandates drug testing in children.
Sinha G
J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
[No Abstract] [Full Text] [Related]
19. Accelerated approval of oncology drugs: can we do better?
Ellenberg SS
J Natl Cancer Inst; 2011 Apr; 103(8):616-7. PubMed ID: 21422401
[No Abstract] [Full Text] [Related]
20. Cancer drug approval in the United States, Europe, and Japan.
Milsted RA
Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
